000			00567nam a22001457a 4500
999			_c19385 _d19385
020			_a9780849377846 (hb)
020			_a0849377846 (hb)
082			_a615.1 _bGEN
100			_aIsadore Kanter (editor) _aLeon Shargel (editor)
245			_aGeneric drug product development _bbioequivalence issues
260			_aNew York _bInforma Health Care _c2008
300			_ax, 264 p. _b: ill. _c; 23 cm.
650			_aDrugs-Equivalency _aDrug- Bioavailability _vDrug products _vPharmaceutical alternatives _vBioequivalence assesment _vVariables drugs _vPharmacodynamics _vRIPS
942			_cBK